Two‐drug antiretroviral regimens: an assessment of virologic response and durability among treatment‐experienced persons living with HIV in the OPERA(®) Observational Database

por Pierone, Gerald, Henegar, Cassidy, Fusco, Jennifer, Vannappagari, Vani, Aboud, Michael, Ragone, Leigh, Fusco, Gregory
Publicado 2019

1265. Effectiveness and Durability of Dolutegravir (DTG)-Based Regimens in Older People Living with HIV (PLWH) from the Veterans Aging Cohort Study (VACS)

por Yan, Lei, Henegar, Cassidy, Gordon, Kirsha, Hicks, Charles, Vannappagari, Vani, Justice, Amy C, Aslan, Mihaela
Publicado 2022

Virologic Effectiveness of Abacavir/Lamivudine with Darunavir/Ritonavir Versus Other Protease Inhibitors in Treatment-Experienced HIV-Infected Patients in Clinical Practice

por Lackey, Philip, Mills, Anthony, Carpio, Felix, Hsu, Ricky, DeJesus, Edwin, Pierone, Gerald, Henegar, Cassidy, Fusco, Jennifer, Fusco, Gregory, Wohlfeiler, Mike
Publicado 2016

1284. Suppressed Switch to DTG/3TC 2-Drug Regimen Vs. BIC- or DTG-Based 3-Drug Regimens

por Pierone, Gerald, Fusco, Jennifer S, Brunet, Laurence, Vannappagari, Vani, Sarkar, Supriya, Henegar, Cassidy, van Wyk, Jean A, Zolopa, Andrew, Fusco, Gregory P
Publicado 2022

Heavily treatment-experienced people living with HIV in the OPERA® cohort: population characteristics and clinical outcomes

por Hsu, Ricky K., Fusco, Jennifer S., Henegar, Cassidy E., Vannappagari, Vani, Clark, Andrew, Brunet, Laurence, Lackey, Philip C., Pierone, Gerald, Fusco, Gregory P.
Publicado 2023

HLA-B*57:01 screening and hypersensitivity reaction to abacavir between 1999 and 2016 in the OPERA(®) observational database: a cohort study

por Mounzer, Karam, Hsu, Ricky, Fusco, Jennifer S., Brunet, Laurence, Henegar, Cassidy E., Vannappagari, Vani, Stainsby, Chris M., Shaefer, Mark S., Ragone, Leigh, Fusco, Gregory P.
Publicado 2019

341. Risk of Type 2 Diabetes Mellitus after Antiretroviral Therapy Initiation in Individuals Living with HIV in the United States

por Hsu, Ricky, Brunet, Laurence, Fusco, Jennifer S, Mounzer, Karam, Vannappagari, Vani, Henegar, Cassidy, van Wyk, Jean A, Curtis, Lloyd D, Lo, Janet, Fusco, Gregory
Publicado 2019

886. The Impact of the COVID-19 Pandemic on Clinical Follow-Up, Monitoring and Regimen Discontinuation for People Living with HIV in the US

por Pierone, Gerald, Fusco, Jennifer S, Brunet, Laurence, Henegar, Cassidy, van Wyk, Jean A, Sarkar, Supriya, Vannappagari, Vani, Zolopa, Andrew, Wohlfeiler, Michael B, Fusco, Gregory
Publicado 2021

978. Changes in BMI Associated with Antiretroviral Regimens in Treatment-Experienced, Virologically Suppressed Individuals Living with HIV

por Mounzer, Karam, Brunet, Laurence, Hsu, Ricky, Fatukasi, Terra, Fusco, Jennifer S, Vannappagari, Vani, Henegar, Cassidy, van Wyk, Jean A, Crawford, Melissa, Lo, Janet, Fusco, Gregory
Publicado 2019

Abacavir Hypersensitivity Reaction Reporting Rates During a Decade of HLA‐B*5701 Screening as a Risk‐Mitigation Measure

por Stainsby, Chris M., Perger, Teodora M., Vannappagari, Vani, Mounzer, Karam C., Hsu, Ricky K., Henegar, Cassidy E., Oyee, James, Urbaityte, Rimgaile, Lane, Charlotte E., Carter, Lindsay M., Pakes, Gary E., Shaefer, Mark S.
Publicado 2018